Armata Pharmaceuticals Inc

NYSE American:ARMPUnited States

Armata Pharmaceuticals, Inc. is a clinical-stage biotechnology company focused on the development of pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections using its bacteriophage-based technology. Th Company is engaged in developing and advancing a pipeline of natural and synthetic phage candidates, including clinical candidates for Pseudomonas aeruginosa, Staphylococcus aureus, and other pathogens. Its two lead candidates addresses both chronic and acute bacterial infections. The Company's first lead candidate focused primarily on chronic bacterial infections is the clinical phage candidate for Pseudomonas aeruginosa. In parallel, it has an acute bacterial infection clinical development plan focused on Staphylococcus aureus bacteremia, a difficult-to-treat and often life-threatening infection.

Contact Information

Headquarters

5005 Mcconnell AveLOS ANGELES, CA, United States 90066

Phone

310-665-2928

Fax

310-665-2963

Executives

Chief Executive Officer, Director

Deborah Birx

Principal Financial Officer, Senior Vice President - Finance

David House

Independent Director

Jules Haimovitz

Independent Director

Odysseas Kostas

Independent Director

Robin Kramer